Nuformix plc
NFX.L · LSE
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£0 | £0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 25% | -124,743.9% | 99.9% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | £0 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£0 | -£0 | -£0 | £0 |